ImaRx Therapeutics' Unattributed VC - III Round

ImaRx Therapeutics raised a round of funding on November 12, 2003. Investors include Edson Moore Healthcare Ventures.

We are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorder…

Articles about ImaRx Therapeutics' Unattributed VC - III Round: